ABB Optical Offers Tangible Hydra-PEG Surfaced Coating on GP Contact Lenses in Paragon Line


Product: Tangible Hydra-PEG Surfaced Coating on Gas Permeable Contact Lenses in Paragon Line of Materials
Top Line: ABB Optical Group announced that its specialty lens lab has been approved by Paragon Vision Sciences to offer Tangible Hydra-PEG surfaced coating technology in its manufacturing of Paragon’s HDS and Fluoroperm gas permeable contact lenses. Tangible Hydra-PEG is a contact lens coating technology that is designed to significantly improve the custom and specialty contact lens wearer’s experience. The technology encapsulates Paragon’s GP lens material in an ultra-thin layer of a PEGbased polymer (polyethylene glycol), creating a lens surface with improved wettability and lubricity.
Close Up: Specifically designed to improve ocular dryness or discomfort associated with contact lens wear, Tangible Hydra-PEG is the only FDA-cleared GP coating of its kind. “Lenses using the Tangible Hydra-PEG coating technology provide GP contact lens wearers with a comfortable, all-day wear experience, drastically lessening their usage of rewetting drops and reducing deposits that require mid-day cleanings,” said Andy Jackson, director of specialty contact lenses for ABB Optical Group. “We are excited to work with Paragon to offer this choice to our customers, so that they can provide their contact lens patients with the best options to meet their optical needs.”
Rich Jeffries, president of Paragon Vision Sciences, added, “Paragon Vision Sciences and ABB have enjoyed a long-standing relationship focused on providing eye care professionals with treatment options and support that not only changes vision, but changes lives. Paragon contact lens materials are developed with cutting edge research, including insights gained from three space shuttle missions. Being able to now offer Tangible Hydra-PEG through ABB Optical will allow us the opportunity to offer enhanced material options that achieves our goal of meeting the needs of practitioners and the patients they serve.”